-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Xeris Biopharma Holdings, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2022 to 2023.
- Xeris Biopharma Holdings, Inc. Operating Lease, Payments for the quarter ending June 30, 2024 was $839K, a 90.7% increase year-over-year.
- Xeris Biopharma Holdings, Inc. Operating Lease, Payments for the twelve months ending June 30, 2024 was $1.93M, a 4.21% decline year-over-year.
- Xeris Biopharma Holdings, Inc. annual Operating Lease, Payments for 2023 was $1.65M, a 23.7% decline from 2022.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)